This ablates the action of type I IFNs causing defective expression of interferon-stimulated genes (ISGs) and compromised antiviral induction, with STAT2 LOF patients exhibiting enhanced susceptibility to viral diseases, including potential susceptibility to attenuated viral strains used in vaccines [38,60]. This evidence concerns the gene STAT2 and viral infectious disease.